Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Psychiatrist and journalist win prize for defending science

Tuesday 20 November 2012


From The Lancet:


The LancetPsychiatrist and journalist win prize for defending science

By Becky McCall
The Lancet, Volume 380, Issue 9855, Page 1725, 17 November 2012
doi:10.1016/S0140-6736(12)61972-2 Cite or Link Using DOI

In recognition of their efforts to champion science despite extreme opposition, a science journalist and psychiatrist have both received the 2012 John Maddox prize. Becky McCall reports.

Last week, the inaugural John Maddox Prize for Standing up for Science 2012 was granted to UK psychiatrist Simon Wessely for his work on chronic fatigue syndrome (CFS) and Fang Shi-min, a freelance journalist from Beijing, China, for revealing clinics using unproven medicine.

The prize is a joint initiative from the journal, Nature, and the charity, Sense About Science, with some support from the Kohn Foundation. The four judges were Philip Campbell, Editor, Nature; Tracey Brown, Director, Sense About Science; Brenda Maddox, wife of the late John Maddox who was an editor at Nature for 22 years and a founding trustee at Sense About Science; and Colin Blakemore, Director of the Centre for the Study of the Senses at the University of London's School of Advanced Study.

Commenting on why the prize was significant for science, Blakemore said: “I think it's crucial people are well informed about science beyond the scientific facts, that they understand the way in which science actually works.”

He added that by recognising both scientists and science journalists, the prize acknowledged that both groups epitomise the importance of standing up for science against manipulation of evidence for political, personal, or commercial gain.

Shi-min was awarded the prize for his bravery and determination in standing up to death threats for his work uncovering clinics in China that promote unproven treatments. The judges also felt his work highlighted the importance of informing a wide public readership about evidence-based medical therapies.

Wessely, professor of psychological medicine at Kings College London (KCL), UK, is an authority on CFS and as a psychiatrist and academic researcher, has treated hundreds of patients with the illness. With his colleagues at KCL, he developed a rehabilitation strategy and later set up one of the first National Health Service programmes for CFS patients who have previously been the subject of ridicule and considered by some to have “yuppie flu”, one of the many myths of the illness that his research helped dispel.

In stark contrast to the beliefs of most patients with CFS and the scientific community, a small but vocal group of objectors believe that psychiatric therapies mock their illness as unreal or imaginary. “Some people just think that the word psychiatry is itself anathema”, remarks Wessely. “Most people, including most of my patients, have a broad view of their illness and accept that we don't have all the answers, but a small group find that unacceptable.”

As a neuroscientist, Blakemore emphasises that CFS is undoubtedly a disorder of the brain. “But some people make a fierce distinction between neurology and psychiatry, which is deeply offensive to people with mental health problems in general. CFS is probably a constellation of clinical conditions, like schizophrenia or dementia.”

Wessely has received both e-mail and telephone threats for his work on CFS, although he says the most sinister is the ceaseless internet slander and deliberate distortion of his work and writings. On police advice he has similar security arrangements to those who do animal research and receives regular security briefings. Wessely's experiences resonate with Blakemore, who has been attacked and threatened for his scientific views in the past. But Blakemore points out that, remarkably, in Wessely's case, the extremists often have CFS themselves and have an almost self-destructive approach, attacking the researchers who are doing their best to understand the condition and help them. “For patients to dismiss this work because it is being done by psychiatrists, and to attack those who are trying to help, is perverse and reveals a long outdated suspicion about the reality of mental illness”, adds Blakemore.

When asked why he had never given up in spite of the persistent attacks he faced, Wessely explained that he always strongly felt the support of his peers and his own patients. Acknowledging his colleagues in the field, Wessely says he is one of many people working on CFS who have had similar experiences. “Maybe I received the prize because I'm probably more visible and I've been around longer. But some of the most persecuted are not psychiatrists but doctors and scientists working in many different disciplines such as infectious diseases, which is why this is considered anti-science. If you arrive at an answer which is not what the extremists want then you become a target.”

The winners each received a certificate and £2000. Wessely announced at the prize ceremony that he was giving half of this money to the Keep Libel Laws out of Science campaign—a cause that would have met with John Maddox's approval.


The above originally appeared here.


Arrow right

More Multimedia



blog comments powered by Disqus
Previous Previous Page